HUP0302860A2 - Nátrium-hidrogén cserélő 1-típusú inhibitor hatású vegyület új etanolátjai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Nátrium-hidrogén cserélő 1-típusú inhibitor hatású vegyület új etanolátjai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0302860A2 HUP0302860A2 HU0302860A HUP0302860A HUP0302860A2 HU P0302860 A2 HUP0302860 A2 HU P0302860A2 HU 0302860 A HU0302860 A HU 0302860A HU P0302860 A HUP0302860 A HU P0302860A HU P0302860 A2 HUP0302860 A2 HU P0302860A2
- Authority
- HU
- Hungary
- Prior art keywords
- ethanolates
- inhibitor
- sodium
- preparation
- new
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title 1
- 102000052126 Sodium-Hydrogen Exchangers Human genes 0.000 title 1
- 108091006672 Sodium–hydrogen antiporter Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- QWTGYYUZGOZLOW-UHFFFAOYSA-N CCO.NC(N)=NC(=O)C=1C=NN(C=2C3=CC=CN=C3C=CC=2)C=1C1CC1 Chemical compound CCO.NC(N)=NC(=O)C=1C=NN(C=2C3=CC=CN=C3C=CC=2)C=1C1CC1 QWTGYYUZGOZLOW-UHFFFAOYSA-N 0.000 abstract 1
- 102100030980 Sodium/hydrogen exchanger 1 Human genes 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 108010093115 growth factor-activatable Na-H exchanger NHE-1 Proteins 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A találmány NHE-1 inhibitor hatású N-(5-ciklopropil-1-kinolin-5-il-1H-pirazol-4-karbonil)-guanidin-etanolát, -monoetanolát és -mezilátsójára, valamint ezek kristályos formáira, a vegyületek előállításieljárására, valamint a vegyületeket hatóanyagként tartalmazógyógyszerkészítményekre vonatkozik. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26545601P | 2001-01-31 | 2001-01-31 | |
PCT/IB2001/002652 WO2002060892A1 (en) | 2001-01-31 | 2001-12-21 | Ethanolates of sodium-hydrogen exchanger type-1 inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP0302860A2 true HUP0302860A2 (hu) | 2003-12-29 |
Family
ID=23010519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0302860A HUP0302860A2 (hu) | 2001-01-31 | 2001-12-21 | Nátrium-hidrogén cserélő 1-típusú inhibitor hatású vegyület új etanolátjai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények |
Country Status (17)
Country | Link |
---|---|
US (1) | US20020147218A1 (hu) |
EP (1) | EP1355899A1 (hu) |
JP (1) | JP2004518686A (hu) |
KR (1) | KR20030069228A (hu) |
CN (1) | CN1479737A (hu) |
AR (1) | AR035740A1 (hu) |
BR (1) | BR0116841A (hu) |
CA (1) | CA2436539A1 (hu) |
CZ (1) | CZ20032017A3 (hu) |
HU (1) | HUP0302860A2 (hu) |
IL (1) | IL156220A0 (hu) |
MX (1) | MXPA03006872A (hu) |
PL (1) | PL363472A1 (hu) |
RU (1) | RU2242472C1 (hu) |
WO (1) | WO2002060892A1 (hu) |
YU (1) | YU51903A (hu) |
ZA (1) | ZA200303891B (hu) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU739403B2 (en) * | 1998-02-27 | 2001-10-11 | Pfizer Products Inc. | N-((substituted five-membered di- or triaza diunsaturated ring)carbonyl) guanidine derivatives for the treatment of ischemia |
US6441176B1 (en) * | 1999-10-29 | 2002-08-27 | Pfizer Inc. | Method for preparing sodium-hydrogen exchanger type 1 inhibitor |
UA72002C2 (en) * | 1999-10-29 | 2005-01-17 | Pfizer Prod Inc | Inhibitors crystals of sodium-hydrogen exchange of 1 type, a method for the preparation thereof (variants), a pharmaceuticalcomposition based thereon and a method for the reduction of tissue damage |
EP1276737A1 (en) * | 2000-04-28 | 2003-01-22 | Pfizer Products Inc. | Sodium-hydrogen exchanger type 1 inhibitor (nhe-1) |
-
2001
- 2001-12-21 RU RU2003123792/04A patent/RU2242472C1/ru not_active IP Right Cessation
- 2001-12-21 CN CNA018203930A patent/CN1479737A/zh active Pending
- 2001-12-21 CZ CZ20032017A patent/CZ20032017A3/cs unknown
- 2001-12-21 PL PL01363472A patent/PL363472A1/xx not_active Application Discontinuation
- 2001-12-21 EP EP01273557A patent/EP1355899A1/en not_active Withdrawn
- 2001-12-21 IL IL15622001A patent/IL156220A0/xx unknown
- 2001-12-21 BR BR0116841-0A patent/BR0116841A/pt not_active IP Right Cessation
- 2001-12-21 HU HU0302860A patent/HUP0302860A2/hu unknown
- 2001-12-21 CA CA002436539A patent/CA2436539A1/en not_active Abandoned
- 2001-12-21 JP JP2002561041A patent/JP2004518686A/ja active Pending
- 2001-12-21 WO PCT/IB2001/002652 patent/WO2002060892A1/en not_active Application Discontinuation
- 2001-12-21 MX MXPA03006872A patent/MXPA03006872A/es unknown
- 2001-12-21 KR KR10-2003-7010041A patent/KR20030069228A/ko not_active Application Discontinuation
- 2001-12-21 YU YU51903A patent/YU51903A/sh unknown
-
2002
- 2002-01-29 AR ARP020100308A patent/AR035740A1/es unknown
- 2002-01-30 US US10/060,601 patent/US20020147218A1/en not_active Abandoned
-
2003
- 2003-05-20 ZA ZA200303891A patent/ZA200303891B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2436539A1 (en) | 2002-08-08 |
JP2004518686A (ja) | 2004-06-24 |
IL156220A0 (en) | 2003-12-23 |
ZA200303891B (en) | 2004-05-20 |
KR20030069228A (ko) | 2003-08-25 |
BR0116841A (pt) | 2004-02-25 |
US20020147218A1 (en) | 2002-10-10 |
MXPA03006872A (es) | 2003-11-13 |
EP1355899A1 (en) | 2003-10-29 |
CN1479737A (zh) | 2004-03-03 |
RU2242472C1 (ru) | 2004-12-20 |
YU51903A (sh) | 2006-05-25 |
WO2002060892A8 (en) | 2003-07-31 |
RU2003123792A (ru) | 2005-01-20 |
CZ20032017A3 (cs) | 2004-05-12 |
PL363472A1 (en) | 2004-11-15 |
AR035740A1 (es) | 2004-07-07 |
WO2002060892A1 (en) | 2002-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9908545A (pt) | Derivado de piperidina, processo para a preparação do mesmo, composto, processo para a preparação do mesmo, e, composição farmacêutica | |
NO20031331L (no) | Substituerte amino-aza-cykloalkaner anvendelige mot malaria | |
NO20050741L (no) | Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den | |
ME00558A (en) | Pyrazole derivatives for treating hiv | |
DE60214179D1 (de) | IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN | |
ATE284690T1 (de) | Antithrombotische diamine | |
NO20070339L (no) | 1-aza-bicyklo[3 3.1]nonaner | |
ATE383339T1 (de) | Amin-derivate zur behandlung von apoptosis | |
NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
BRPI0406717A (pt) | Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção | |
BR0309498A (pt) | Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças que são relacionadas com o ras, e, uso de compostos | |
ATE300541T1 (de) | Pyrazolopyridinderivate | |
BR9916004A (pt) | Inibidores de proteinase c de pró-colágeno | |
NO20040881L (no) | Orale antidiabetes midler. | |
BRPI0416287A (pt) | compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por inibidores de accß e sua utilização | |
NO20083738L (no) | Sekundaere aminer som renininhibitorer | |
UY27410A1 (es) | Formas novedosas crudas cristalinas | |
BR0212535A (pt) | Compostos e composições como inibidores de catepsina | |
TR200402755T4 (tr) | Bisiklik, N-açillenmiş imidazo-3-aminleri ve imidazo-5-aminlerinin tuları. | |
NO20025015D0 (no) | Et pyridin-1-oksidderivat, og fremgangsmåte for dets overföring til farmasöytisk effektive forbindelser | |
BR0314860A (pt) | Derivados de pirazol | |
ATE253359T1 (de) | Antithrombotische mittel | |
TR200003065T2 (tr) | Nöraminidazların inhibitörleri olarak pirolidinler. | |
ATE274515T1 (de) | Pyrazolopyridinderivate | |
HUP0302860A2 (hu) | Nátrium-hidrogén cserélő 1-típusú inhibitor hatású vegyület új etanolátjai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |